CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – May 05, 2023

CTI BioPharma Corp. announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Company’s Amended and Restated 2017 Equity Incentive Plan and material to the employee’s acceptance of employment with the company.

Scroll to Top